When Alliance Defending Freedom attorney Kate Anderson opened her computer to draft a letter to major retailers last month, she knew the stakes were high. The legal advocacy group had launched a targeted campaign to convince companies like Costco, Walmart and CVS not to join the growing list of pharmacies dispensing mifepristone, the abortion drug that has become increasingly available since the Supreme Court overturned Roe v. Wade.
This week, Anderson’s efforts paid off. Costco confirmed it will not sell abortion pills, citing “lack of demand” for the decision. But pro-life advocates aren’t buying the company’s explanation, instead crediting persistent lobbying pressure with convincing the retail giant to stay out of the abortion business entirely.
“Maximizing shareholder value requires Costco to avoid politicizing its services and to continue to do what it has always done best, provide excellent grocery and retail goods to families,” ADF wrote in their lobbying campaign materials sent to retailers across the country. “The ‘growing market opportunity’ of abortion drugs is legally and politically fraught, raises significant reputational issues, and reduces the company’s customer base, both literally and because it would drive away many existing customers.”
The decision represents a significant victory for pro-life organizations who have watched abortion pill distribution expand rapidly following the Dobbs v. Jackson Women’s Health Organization ruling in 2022. While that landmark decision returned abortion regulation to individual states, the proliferation of chemical abortion through retail pharmacies has created new battlegrounds in the fight to protect unborn life.
Costco’s wholesale club membership model serves millions of American families, many of whom hold traditional values regarding the sanctity of life. The company’s decision to avoid entering what ADF accurately described as a “legally and politically fraught” market reflects a business calculation that goes beyond simple demand metrics. With abortion pills now accounting for more than half of all abortions in the United States, claims of insufficient demand ring hollow to seasoned pro-life activists.
The Catholic Church’s teaching on this issue provides clear moral guidance. Pope St. John Paul II’s encyclical Evangelium Vitae explicitly states that “laws which authorize and promote abortion and euthanasia are radically opposed not only to the good of the individual but also to the common good.” This principle extends to private entities who, while not bound by the same obligations as governments, still bear moral responsibility for their participation in what the Church considers intrinsic evils.
Dr. Michael New, a research associate at the Catholic University of America who studies abortion trends, notes that corporate decisions like Costco’s carry weight beyond their immediate business impact. “When major retailers choose not to dispense abortion drugs, they’re making a statement about the kind of society they want to support,” New explains. “This sends a signal that not every legal product deserves a place on pharmacy shelves.”
The legal landscape surrounding abortion pill distribution remains complex, particularly after Dobbs returned regulatory authority to state governments. Conservative constitutional scholars argue that federal agencies cannot override state sovereignty by mandating that private businesses participate in abortion provision. The Religious Freedom Restoration Act provides additional protection for entities that object to practices conflicting with deeply held religious beliefs.
Alliance Defending Freedom’s strategy focused on practical business concerns rather than purely moral arguments. Their research highlighted the reputational risks companies face when entering controversial medical territory, pointing to boycotts and consumer backlash that have affected other corporations taking political stances. This approach proved persuasive with Costco’s leadership, who built their brand on providing quality goods to families rather than wading into divisive social issues.
The success of the ADF campaign demonstrates the continued effectiveness of organized pro-life advocacy in the post-Roe era. Rather than accepting the expansion of chemical abortion as inevitable, pro-life organizations are actively engaging corporations, policymakers and communities to limit access to drugs that end human life. This represents a shift from the reactive posture many pro-life groups maintained during the nearly five decades when Roe was settled law.
For Catholics and other Christians who believe in the inherent dignity of every human life, Costco’s decision offers encouragement that moral principles still influence business decisions in America. The company’s choice to prioritize its core mission of serving families over potential profits from abortion drugs reflects values that align with natural law teachings on the protection of innocent life.
The broader implications extend beyond one company’s policy decision. As more retailers face pressure to dispense abortion pills, the success of targeted advocacy campaigns like ADF’s could influence additional corporations to reconsider their involvement in the abortion industry. Pro-life organizations are now studying the Costco campaign as a model for future efforts to limit the commercialization of chemical abortion.
This victory also highlights the importance of Catholics and conservatives engaging actively in the public square. The Second Vatican Council’s document Gaudium et Spes calls the faithful to participate in public life, working to ensure that civil laws reflect moral truth. The success of the Costco campaign shows how organized advocacy, grounded in solid principles and practical arguments, can achieve concrete results in protecting human life.
Moving forward, pro-life advocates plan to expand their corporate engagement efforts, recognizing that the battle for life now extends beyond legislatures and courts into boardrooms and business decisions. The Costco victory proves that companies will respond to well-reasoned arguments about the legal, financial and reputational risks of participating in the abortion industry, especially when those arguments come from organized constituencies representing millions of customers.
